Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms-Reference-Cited by-同舟云学术

Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms

Published:2005 Issue:8 Volume:26 Page:321-334
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Agrawal Shrutidevi,Panchagnula Ramesh

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Reference55 articles.

1. WHO Report 2003. Global Tuberculosis Control. Surveillance, Planning, Financing. WHO/CDS/TB/2003.316. World Health Organization: Geneva.

2. WHO Report 2002. Global Tuberculosis Control. Surveillance, Planning, Financing. WHO/CDS/TB/2002.295. World Health Organization: Geneva.

3. , , . Informal Consultation on 4-drug Fixed Dose Combinations (4FDCs) Compliant with the WHO Model List of Essential Drugs. 15-17 August 2001. WHO/CDS/TB/2002.299. World Health Organization: Geneva.

4. , , et al. Fixed-dose Combination Tablets for the Treatment of Tuberculosis. Report of an Informal Meeting held in Geneva Tuesday, 27 April 1999, WHO/CDS/CPC/TB/99.267. World Health Organization: Geneva.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Core-shell electrospun polycaprolactone nanofibers, loaded with rifampicin and coated with silver nanoparticles, for tissue engineering applications;Biomaterials Advances;2025-01

2. Biowaiver based on biopharmaceutics classification system: Considerations and requirements;Pharmaceutical Science Advances;2024-12

3. Mixed metal oxide (Ru, Ir, Sn) electrodes in the anodic activation of peroxydisulfate for a sustainable degradation of rifampicin;Journal of Industrial and Engineering Chemistry;2024-10

4. Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter?;Pharmaceutics;2024-07-23

5. Cannabidiol-Based Prodrugs: Synthesis and Bioevaluation;ACS Medicinal Chemistry Letters;2024-01-16